Philips sells 70% of MedQuist for $285M

Royal Philips Electronics has completed the sale of its approximate 69.5 percent ownership interest in MedQuist to CBaySystems Holdings for about $285 million.

Philips said the financial results related to the transaction will be booked under ‘Discontinued Operations’ in its third quarter 2008 results.

Pursuant to the stock purchase agreement, the directors of MedQuist appointed by Philips have stepped down.

The New York City-based CBaySystems has an existing portfolio of businesses in medical transcription, healthcare technology and healthcare financial services, including CBay Systems & Services, CBay Systems Private and Mirrus Systems.

Around the web

RBMA President Peter Moffatt discusses some of the biggest obstacles facing the specialty in the new year. 

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.